M. Gerlinger
发表
P. A. Futreal,
N. Matthews,
I. Varela,
2014,
Nature Genetics.
Joel s. Brown,
K. Pienta,
M. Greaves,
2017,
Nature Reviews Cancer.
Charles Swanton,
Lajos Pusztai,
P. A. Futreal,
2012,
Science Translational Medicine.
P. A. Futreal,
Z. Szallasi,
N. Matthews,
2012,
The New England journal of medicine.
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
M. Gerlinger,
C. Swanton,
2010,
British Journal of Cancer.
Z. Szallasi,
Clarence C Lee,
T. Harkins,
2014,
Science.
Matthew N Davies,
M. Gerlinger,
M. Davies,
2015,
Current opinion in genetics & development.
Charles Swanton,
Ian Tomlinson,
Nicholas McGranahan,
2014,
Annual review of genetics.
M. Gerlinger,
D. Cunningham,
N. Starling,
2018,
Critical reviews in oncology/hematology.
G. Sauter,
M. Gerlinger,
A. Marx,
2019,
Nature Communications.
Z. Szallasi,
M. Stratton,
N. Matthews,
2015,
Oncogene.
Z. Szallasi,
M. Gerlinger,
N. McGranahan,
2017,
Annals of oncology : official journal of the European Society for Medical Oncology.
Z. Szallasi,
M. Gerlinger,
J. Larkin,
2013,
The Journal of pathology.
L. Norton,
M. Gerlinger,
C. Swanton,
2013,
The New England journal of medicine.
H. Heng,
M. Gerlinger,
A. Marusyk,
2022,
Medical Oncology.
Z. Szallasi,
M. Gerlinger,
A. Rowan,
2013
.
M. Gerlinger,
D. Koh,
C. Braconi,
2020
.
M. Gerlinger,
C. Braconi,
A. Wotherspoon,
2018,
Annals of oncology : official journal of the European Society for Medical Oncology.
Robin L. Jones,
M. Gerlinger,
K. Harrington,
2020,
European Journal of Cancer.
H. Grabsch,
M. Gerlinger,
K. von Loga,
2020,
Journal of the National Cancer Institute.
H. Moch,
M. Gerlinger,
A. Agaimy,
2022,
Genome Medicine.
Z. Szallasi,
M. Gerlinger,
J. Larkin,
2013,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
M. Gerlinger,
2021,
Cancer cell.
M. Gerlinger,
2018,
Clinical Cancer Research.
David R. Klug,
Keith R. Willison,
David Cunningham,
2017
.
M. Gerlinger,
N. Starling,
H. Lote,
2022,
Cancer treatment reviews.
H. Moch,
M. Gerlinger,
A. Agaimy,
2022
.
H. Heng,
M. Gerlinger,
A. Marusyk,
2022,
Medical Oncology.
K. Flaherty,
D. Cescon,
M. Gerlinger,
2022,
JCO precision oncology.
M. Gerlinger,
F. Klauschen,
V. Heinemann,
2022,
Journal of Cancer Research and Clinical Oncology.
L. Bonne,
M. Gerlinger,
D. Koh,
2020,
European Radiology.
M. Gerlinger,
H. Pandha,
I. Tomlinson,
2019,
Journal of Clinical Oncology.
M. Gerlinger,
T. Lund,
K. Fenwick,
2022,
bioRxiv.
Charles Swanton,
B. Teh,
M. Gerlinger,
2010,
European journal of cancer.
F. Real,
M. Gerlinger,
C. Swanton,
2015,
European urology.
Andrea Sottoriva,
Matthew N Davies,
M. Gerlinger,
2016,
Trends in cancer.
N. López-Bigas,
M. Gerlinger,
D. Cunningham,
2021,
Nature Ecology & Evolution.
M. Gerlinger,
P. Martinez,
C. Swanton,
2013,
Scientific Reports.
Antoine M. Dujon,
Joel s. Brown,
K. Pienta,
2021,
Evolutionary applications.
M. Gerlinger,
D. Alpár,
L. Barber,
2015
.
M. Gerlinger,
D. Cunningham,
I. Assiotis,
2019,
Cancers.
M. Gerlinger,
M. Davies,
K. von Loga,
2018,
bioRxiv.
M. Gerlinger,
M. Davies,
K. von Loga,
2018,
bioRxiv.
M. Gerlinger,
D. Cunningham,
Nik Matthews,
2020,
bioRxiv.
M. Gerlinger,
D. Cunningham,
I. Chau,
2017,
Clinical colorectal cancer.
Z. Szallasi,
P. Futreal,
A. Eklund,
2010,
Genome Medicine.
M. Gerlinger,
L. Albiges,
2012
.
Zoltan Szallasi,
Paul A. Bates,
Charles Swanton,
2014,
European urology.
Francesco Favero,
Ignacio Varela,
Charles Swanton,
2014,
Genome Biology.
M. Gerlinger,
J. Choudhary,
M. Bassani-Sternberg,
2022,
bioRxiv.
D. Berney,
Yong-jie Lu,
M. Gerlinger,
2013,
Clinical Cancer Research.
A. Camargo,
M. Gerlinger,
Dimitrios Kleftogiannis,
2020,
Cancers.
Brian J. Stevenson,
G. Coukos,
M. Gerlinger,
2019,
Journal of Immunotherapy for Cancer.
M. Gerlinger,
D. Koh,
C. Braconi,
2020,
Frontiers in Oncology.
M. Gerlinger,
D. Koh,
C. Braconi,
2020,
medRxiv.
D. Cescon,
M. Gerlinger,
J. Sosman,
2022,
medRxiv.
Benjamin Haibe-Kains,
Zoltan Szallasi,
Charles Swanton,
2010,
The Lancet. Oncology.
Charles Swanton,
Nicholas McGranahan,
M. Gerlinger,
2013,
The Journal of pathology.
M. Gerlinger,
M. Davies,
B. Herman,
2018,
Clinical chemistry.
Z. Szallasi,
D. Bentley,
S. Humphray,
2015,
Annals of oncology : official journal of the European Society for Medical Oncology.
D. Jäger,
R. Dummer,
M. Gerlinger,
2006,
The Journal of Immunology.
S. Montoto,
T. A. Lister,
M. Gerlinger,
2010,
Haematologica.
M. Gerlinger,
H. Pandha,
I. Tomlinson,
2020,
ESMO Open.
M. Gerlinger,
K. von Loga,
2017,
Nature Ecology & Evolution.
D. Jäger,
R. Dummer,
M. Gerlinger,
2013
.
M. Gerlinger,
2019,
Science.
M. Gerlinger,
J. D. de Bono,
J. Mateo,
2014,
Genome Biology.
M. Gerlinger,
Judith P. Johnson,
J. Kumbrink,
2005,
Journal of Biological Chemistry.
Karl J. Dykema,
N. Rioux-Leclercq,
J. Patard,
2012,
The Journal of pathology.
M. Gerlinger,
K. von Loga,
D. Cunningham,
2019,
Journal of Immunotherapy for Cancer.
M. Gerlinger,
C. Braconi,
D. Cunningham,
2019,
Clinical colorectal cancer.
Peter C. Ellsworth,
M. Gerlinger,
C. Maley,
2023,
2304.00402.
M. Gerlinger,
P. Souček,
D. Hughes,
2023,
Microbiome.
M. Gerlinger,
D. Cunningham,
Sacheen Kumar,
2021
.
M. Gerlinger,
T. Powles,
W. Prevoo,
2016,
BMC Medicine.
M. Gerlinger,
R. Bhogal,
W. Allum,
2022,
BJS open.
M. Gerlinger,
G. Spain,
G. Spain,
2020
.
Z. Szallasi,
L. Alexandrov,
M. Gerlinger,
2015,
Oncogene.
Z. Szallasi,
A. Eklund,
Qiyuan Li,
2009
.
M. Gerlinger,
K. von Loga,
2017,
Nature Ecology & Evolution.
M. Gerlinger,
T. Powles,
J. Shamash,
2010,
European journal of cancer.
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
M. Gerlinger,
C. Swanton,
2010,
British Journal of Cancer.
Z. Szallasi,
Clarence C Lee,
T. Harkins,
2014,
Science.
D. Berney,
M. Gerlinger,
I. Kayani,
2013,
Clinical Cancer Research.
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
M. Gerlinger,
Charles Swanton,
2010,
British Journal of Cancer.
M. Gerlinger,
S Kumar,
I. Chau,
2023,
Journal of Clinical Oncology.